Example: Heart Attack

Clinical Trials Sponsored by MacuSight, Inc

Total 6 results

    • NCT00814944
      Completed
      A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model
      Conditions: Dry Eye
    • NCT00766337
      Terminated
      Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration
      Conditions: Age-Related Macular Degeneration; Choroidal Neovascularization
    • NCT00712491
      Terminated
      Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration
      Conditions: Age-related Macular Degeneration; Choroidal Neovascularization
    • NCT00656643
      Completed
      Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema
      Conditions: Diabetic Macular Edema
    • NCT00401115
      Completed
      Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
      Conditions: Diabetic Macular Edema; Diabetic Retinopathy
    • NCT00908466
      Completed
      Sirolimus as Therapeutic Approach to Uveitis
      Conditions: Uveitis; Intermediate Uveitis; Posterior Uveitis; Panuveitis
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations